Gary Cook
12Patents
4h-index
23Co-inventors
56Inventor score
Filing activity: Jul 15, 2004 → Nov 28, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8088754B2 | Anti-proliferative compounds, compositions, and methods of use thereof | Emerging Cross-Sectional Technologies | 21 | Active |
| US7553825B2 | Anti-proliferative compounds, compositions, and methods of use thereof | Emerging Cross-Sectional Technologies | 9 | Expired |
| US8268802B2 | Anti-proliferative compounds, compositions, and methods of use thereof | Emerging Cross-Sectional Technologies | 5 | Active |
| US10376463B2 | Ocular iontophoretic delivery of dexamethasone and formulations thereof | Human Necessities | 5 | Active |
| US8900636B2 | Controlled release compositions | Human Necessities | 1 | Active |
| US8871269B2 | Method for the preparation of controlled release formulations | Emerging Cross-Sectional Technologies | 1 | Active |
| US9149525B2 | Delivery of corticosteroids through iontophoresis | Human Necessities | 1 | Active |
| US8877229B2 | Controlled release microparticles | Human Necessities | 0 | Active |
| US9849100B2 | Pharmaceutical compositions suitable for parenteral administration comprising aqueous suspensions of benzylamine derivatives having low solubilities | Human Necessities | 0 | Active |
| US11234939B2 | Dosage forms comprising a plasma kallikrein inhibitor | Chemistry; Metallurgy | 0 | Active |
| US10478409B2 | Pharmaceutical compositions | Human Necessities | 0 | Active |
| US9820935B2 | Delivery of corticosteroids through iontophoresis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.